Glaxosmithkline Consumer Nigeria Plc (GLAXOS.ng) HY2013 Interim Report

first_imgGlaxosmithkline Consumer Nigeria Plc (GLAXOS.ng) listed on the Nigerian Stock Exchange under the Pharmaceuticals sector has released it’s 2013 interim results for the half year.For more information about Glaxosmithkline Consumer Nigeria Plc (GLAXOS.ng) reports, abridged reports, interim earnings results and earnings presentations, visit the Glaxosmithkline Consumer Nigeria Plc (GLAXOS.ng) company page on AfricanFinancials.Document: Glaxosmithkline Consumer Nigeria Plc (GLAXOS.ng)  2013 interim results for the half year.Company ProfileGlaxosmithkline Consumer Nigeria Plc manufactures and markets a range of consumer healthcare and pharmaceutical products in Nigeria. Its product portfolio includes treatments for asthma, HIV/AIDS, malaria, depression, migraines, diabetes, heart failure, digestive ailments and cancer. Consumer healthcare products include oral healthcare products; wellness products for the management of pain, gastro-intestinal and respiratory conditions; multivitamins; and a range of nutritional healthcare beverages. Glaxosmithkline Consumer Nigeria Plc produces a range of antibacterial products and vaccines to protect against illnesses such as hepatitis A and B, diphtheria, tetanus, whooping cough, typhoid, influenza and cervical cancer. The company was formerly known as Beecham Limited. Its head office is in Lagos, Nigeria. Glaxosmithkline Consumer Nigeria Plc is listed on the Nigerian Stock Exchangelast_img read more